Funding Citations

The OneFlorida+ Clinical Research Network is supported by multiple funding agencies and grant awards. All publications, manuscripts and presentations must acknowledge the funding agency with the inclusion of an acknowledgement statement like the following:

Research reported in this publication was supported in part by the OneFlorida Clinical Data Network, funded by the Patient-Centered Outcomes Research Institute numbers CDRN-1501-26692 and RI-CRN-2020-005; in part by the OneFlorida Cancer Control Alliance, funded by the Florida Department of Health’s James and Esther King Biomedical Research Program number 4KB16; and in part by the University of Florida Clinical and Translational Science Institute and its Clinical and Translational Science Award (CTSA) hub partner, Florida State University, which are supported in part by three CTSA Program grants awarded on August 15, 2015, and renewed for five years on July 2, 2019, by the National Center for Advancing Translational Sciences of the National Institutes of Health. The UF-FSU CTSA grant numbers are UL1TR001427, KL2TR001429 and TL1TR001428. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology, the OneFlorida Clinical Research Consortium, the UF-FSU Clinical and Translational Science Institute, the Florida Department of Health, or the National Institutes of Health.

Agency Reporting

The OneFlorida Clinical Research Consortium is contractually required to track the submission of all publications citing the CDRN contract. Please contact onefloridaoperations@health.ufl.edu before preparing publications or presentations.

The OneFlorida+ Administrative Team reports on publication, manuscript and presentation development to funders on a rolling basis. Writing groups are responsible for communicating the publication’s author(s), publication date, title, type of publication, name of journal and status to the OneFlorida+ Administrative Team.

Patient-Centered Outcomes Research Institute

Infrastructure support for the OneFlorida+ Clinical Research Network’s Clinical Data Research Network (CDRN) is provided by the Patient-Centered Outcomes Research Institute (PCORI), which aims to improve the quality and relevance of evidence available to help patients, caregivers, clinicians, employers, insurers and policy-makers make informed health decisions.

James and Esther King Biomedical Research Program, Florida Department of Health

The OneFlorida Cancer Control Alliance is funded by the Florida Department of Health’s James and Esther King Biomedical Research Program. The James and Esther King Biomedical Research Program has several goals, including improving the health of Floridians through research into better prevention, diagnoses, treatments and cures for cancer, cardiovascular disease, stroke and pulmonary disease. To learn more about this program, visit http://www.floridahealth.gov/provider-and-partner-resources/research/research-cancer-tobacco.html.

Please use the following number when citing the grant: #4KB16.

National Institutes of Health’s Clinical and Translational Science Awards Program

Infrastructure support for the OneFlorida+ Clinical Research Network is provided by the University of Florida’s National Institutes of Health National Center for Advancing Translational Science (NCATS) Award. NCATS was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster. To learn more about NCATS, visit https://ncats.nih.gov/about.

The University of Florida Clinical and Translational Science Institute and its Clinical and Translational Science Award (CTSA) hub partner, Florida State University, are supported in part by three CTSA Program grants awarded on August 15, 2015, and renewed for five years on July 2, 2019, by the National Center for Advancing Translational Sciences of the National Institutes of Health. The UF-FSU CTSA grant numbers are UL1TR001427, KL2TR001429 and TL1TR001428. Please use the following language when citing the grant:

“Research reported in this publication was supported by the University of Florida Clinical and Translational Science Institute and its Clinical and Translational Science Award (CTSA) hub partner, Florida State University, which are supported in part by three CTSA Program grants awarded on August 15, 2015, and renewed for five years on July 2, 2019, by the National Center for Advancing Translational Sciences of the National Institutes of Health. The UF-FSU CTSA grant numbers are UL1TR001427, KL2TR001429 and TL1TR001428. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”